Open-Label Extension and Safety Study of Talazoparib
Public ClinicalTrials.gov record NCT02921919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A SINGLE-ARM, OPEN-LABEL, MULTICENTER, EXTENDED TREATMENT, SAFETY STUDY IN PATIENTS TREATED WITH TALAZOPARIB
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a single-arm, open-label, extended treatment, safety study in patients treated with talazoparib in qualifying studies.
Study identification
- NCT ID
- NCT02921919
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 8, 2016 (Actual)
- Primary completion
- Jul 20, 2021 (Actual)
- Completion
- Jul 20, 2021 (Actual)
- Last update posted
- Aug 24, 2022
2016 – 2021
United States locations
- U.S. sites
- 26
- U.S. states
- 6
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Hematology/Oncology - Alhambra | Alhambra | California | 91801 | — |
| CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center | Bakersfield | California | 93309 | — |
| UCLA Hematology/Oncology - Burbank | Burbank | California | 91505 | — |
| St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare | Fullerton | California | 92835 | — |
| UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D. | Los Angeles | California | 90095-7349 | — |
| (IRB# 16-001189) Ronald Reagan UCLA Medical Center, Drug Information Center | Los Angeles | California | 90095 | — |
| TRIO-US Central Administration | Los Angeles | California | 90095 | — |
| UCLA Hematology/Oncology | Los Angeles | California | 90095 | — |
| UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D. | Los Angeles | California | 90095 | — |
| UCLA Hematology/Oncology - Pasadena | Pasadena | California | 91105 | — |
| UCLA Hematology/Oncology - Porter Ranch | Porter Ranch | California | 91326 | — |
| UCLA Hematology/Oncology - Santa Monica | Santa Monica | California | 90404 | — |
| UCLA Torrance Oncology | Torrance | California | 90505 | — |
| UCLA Hematology/Oncology - Santa Clarita | Valencia | California | 91355 | — |
| Orlando Health, Inc. | Orlando | Florida | 32806 | — |
| Memorial Hospital West | Pembroke Pines | Florida | 33028 | — |
| IU Health Bloomington Hospital | Bloomington | Indiana | 47403 | — |
| Fort Wayne Medical Oncology and Hematology, Inc. | Fort Wayne | Indiana | 46804 | — |
| Fort Wayne Medical Oncology and Hematology, Inc. | Fort Wayne | Indiana | 46845 | — |
| Indiana University Health Melvin and Bren Simon Cancer Center | Indianapolis | Indiana | 46202 | — |
| Investigational Drug Senvices | Indianapolis | Indiana | 46202 | — |
| IU Health University Hospital | Indianapolis | Indiana | 46202 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02921919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2022 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02921919 live on ClinicalTrials.gov.